Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.

[1]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text , 2006 .

[2]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[3]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[4]  J. Lingrel,et al.  The α1 Isoform of Na,K-ATPase Regulates Cardiac Contractility and Functionally Interacts and Co-localizes with the Na/Ca Exchanger in Heart* , 2004, Journal of Biological Chemistry.

[5]  R. Schwinger,et al.  Sodium pump isoform expression in heart failure: implication for treatment , 2002, Basic Research in Cardiology.

[6]  J. Lingrel,et al.  Ouabain and substrate affinities of human Na+-K+-ATPase α1β1, α2β1, and α3β1when expressed separately in yeast cells , 2001 .

[7]  R. Schwinger,et al.  Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle. , 2001, Cellular and molecular biology.

[8]  Jean-Daniel Horisberger,et al.  Transport and Pharmacological Properties of Nine Different Human Na,K-ATPase Isozymes* , 2000, The Journal of Biological Chemistry.

[9]  R. Walsh,et al.  Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. , 1999, Molecular cell.

[10]  Konrad Frank,et al.  Reduced Sodium Pump α1, α3, and β1-Isoform Protein Levels and Na+,K+-ATPase Activity but Unchanged Na+-Ca2+ Exchanger Protein Levels in Human Heart Failure , 1999 .

[11]  R. Hullin,et al.  Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts. , 1999, Journal of molecular and cellular cardiology.

[12]  G. Blanco,et al.  Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. , 1998, American journal of physiology. Renal physiology.

[13]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[14]  Konrad Frank,et al.  Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. , 1996, The Journal of clinical investigation.

[15]  A. McDonough,et al.  Subcellular distribution of sodium pump isoform subunits in mammalian cardiac myocytes. , 1996, The American journal of physiology.

[16]  C. L. Johnson,et al.  Comparison of the effects of potassium on ouabain binding to native and site-directed mutants of Na,K-ATPase. , 1995, Archives of biochemistry and biophysics.

[17]  J. Lingrel,et al.  Identification of an amino acid substitution in human alpha 1 Na,K-ATPase which confers differentially reduced affinity for two related cardiac glycosides. , 1994, Journal of Biological Chemistry.

[18]  K. Kim,et al.  High-affinity ouabain binding by yeast cells expressing Na+, K(+)-ATPase alpha subunits and the gastric H+, K(+)-ATPase beta subunit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Böhm,et al.  Different β‐adrenoceptor‐effector coupling in human ventricular and atrial myocardium , 1991, European journal of clinical investigation.

[20]  S. Sterkowicz.  [In memory of William Withering (1741-1799). On the 200th anniversary of the work, "An account of the foxglove and some of its medical uses"]. , 1985, Wiadomosci lekarskie.

[21]  E. Erdmann,et al.  Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. , 1973, Biochimica et biophysica acta.

[22]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.